Quince Therapeutics (QNCX) rated Buy ahead of Phase 3 NEAT readout in A-T; eDSP targets $1B+ orphan market with strong cash ...

Currently, it takes a nine-figure asking price to be included among the most expensive private residences available for ...

Access the comprehensive CBSE Class 11 Maths deleted syllabus for 2025-26. Find out which topics have been removed to ...

Decade Resources Ltd (TSXV: DEC) ("Decade" or the Company) is providing results of its exploration program on the Nobody ...

Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients ...